Compare · DXCM vs UFPT
DXCM vs UFPT
Side-by-side comparison of DexCom Inc. (DXCM) and UFP Technologies Inc. (UFPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and UFPT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $29.57B, about 16.9x UFPT ($1.75B).
- Over the past year, DXCM is down 10.6% and UFPT is down 4.4% - UFPT leads by 6.1 points.
- DXCM has been more active in the news (26 items in the past 4 weeks vs 17 for UFPT).
- DXCM has more recent analyst coverage (25 ratings vs 7 for UFPT).
- Company
- DexCom Inc.
- UFP Technologies Inc.
- Price
- $76.59+5.15%
- $229.46+3.08%
- Market cap
- $29.57B
- $1.75B
- 1M return
- +25.71%
- +2.52%
- 1Y return
- -10.56%
- -4.43%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- 1993
- News (4w)
- 26
- 17
- Recent ratings
- 25
- 7
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
UFP Technologies Inc.
UFP Technologies, Inc. designs and converts foams, films, and plastics materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components for automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts. The company markets and sells its products through direct sales forces and independent manufacturer representatives. UFP Technologies, Inc. was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Latest DXCM
- Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
- EVP, Chief Commercial Officer Coleman Jon sold $722,628 worth of shares (9,823 units at $73.56) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 95,450 units (SEC Form 4)
- Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
- Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
- Director Altman Steven R was granted 5,565 shares (SEC Form 4)
- Director Augustinos Nicholas was granted 5,575 shares (SEC Form 4)
- Director Malady Kyle was granted 5,575 shares, increasing direct ownership by 25% to 28,242 units (SEC Form 4)
- Director Heller Bridgette P was granted 5,575 shares, increasing direct ownership by 22% to 30,582 units (SEC Form 4)
- Director Osterloh Albert Frederick Iv was granted 1,630 shares, increasing direct ownership by 23% to 8,691 units (SEC Form 4)
- Director Foletta Mark G was granted 6,331 shares (SEC Form 4)
Latest UFPT
- Executive Chairman Bailly R Jeffrey was granted 1,787 shares and covered exercise/tax liability with 750 shares, increasing direct ownership by 0.61% to 171,200 units (SEC Form 4)
- SVP Human Resources Stafford Ryan K was granted 1,448 shares (SEC Form 4)
- New insider Stafford Ryan K claimed no ownership of stock in the company (SEC Form 3)
- UFP Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Financial Officer Lataille Ronald J was granted 4,454 shares, increasing direct ownership by 28% to 20,352 units (SEC Form 4)
- President Rock Mitchell was granted 2,895 shares, increasing direct ownership by 8% to 39,115 units (SEC Form 4)
- Director Hassett Joseph John was granted 802 shares, increasing direct ownership by 49% to 2,425 units (SEC Form 4)
- Director Hudson Symeria was granted 802 shares, increasing direct ownership by 70% to 1,955 units (SEC Form 4)
- Director Feldmann Cynthia L was granted 802 shares, increasing direct ownership by 17% to 5,476 units (SEC Form 4)
- Director Croteau Daniel C was granted 802 shares, increasing direct ownership by 94% to 1,657 units (SEC Form 4)